This entity has not been resolved onto another DFX graph by a shared identifier. A name match elsewhere would be a candidate, never an identity, and none is recorded.

Adviser

LEERINK PHARMACEUTICAL INVESTMENTS LLCCRD 172514

Fund type

Hedge Fund

Latest reported GAV

$10,000gross asset value on Schedule D 7.B(1), as of 2017-12-14; never fund size

Peak reported GAV

$82.6M

Beneficial owners

6

Minimum investment

$1.0M

Owned by the adviser

600%

Owned by funds of funds

8900%

Owned by non-US persons

8900%

Clients solicited

no

Form D file number

021-219920an SEC offering identifier; the Form D vehicle on the venture or private equity graph is linked above when the identity layer has it

Organised in

Massachusetts, United States

First reported

Aug 20, 2014

Last reported

Dec 14, 2017fund reporting on the SEC extract ends 2024-12-31

Filings reporting it

10

Fund id

805-4096465398

Graph

RIA / Wealth Management

Canonical id

dfx:ria:e5526e2a-cc15-124b-3fd0-3f08d78cccfb

First observed

Aug 20, 2014

Last observed

Dec 14, 2017 106 months ago

Source families

Federal regulator filings

1 registered feed stand behind this record; each fact above carries its own dates and, where the publisher serves one, its document.

Resolution

Identity across graphs by shared identifier (CRD, CIK, EIN, ADV fund id, individual CRD) or citation; a name match is shown as a candidate and never merged.